Global Newcastle Disease Vaccine Market Research Report 2023(Status and Outlook)
Report Overview
Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.
Market competition is intense. Merial, CEVA, QYH Biotech, Ringpu Biology and Yebio, etc. are the leader of this industry. They got about 63% market shares. Asia-Pacific is the largest consumption place, with a consumption market share nearly 56%. Following Asia-Pacific, North America is the second largest consumption place with the consumption market share of 2%.
The Global Newcastle Disease Vaccine Market Size was estimated at USD 304.90 million in 2022 and is projected to reach USD 382.70 million by 2029, exhibiting a CAGR of 3.30% during the forecast period.
Bosson Research’s latest report provides a deep insight into the global Newcastle Disease Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Newcastle Disease Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Newcastle Disease Vaccine market in any manner.
Global Newcastle Disease Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merial
CEVA
QYH Biotech
Ringpu Biology
Yebio
Harbin Veterinary Research Institute
Merck Animal Health
DHN
Zoetis
ChengDu Tecbond
Elanco (Lohmann)
FATRO
CAVAC
Vaksindo
Market Segmentation (by Type)
Live Vaccines
Killed Vaccines
Market Segmentation (by Application)
Food & Ingredients
Dairy
Beverages
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Newcastle Disease Vaccine Market
Overview of the regional outlook of the Newcastle Disease Vaccine Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Newcastle Disease Vaccine
- 1.2 Key Market Segments
- 1.2.1 Newcastle Disease Vaccine Segment by Type
- 1.2.2 Newcastle Disease Vaccine Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Newcastle Disease Vaccine Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Newcastle Disease Vaccine Market Size (M USD) Estimates and Forecasts (2018-2029)
- 2.1.2 Global Newcastle Disease Vaccine Sales Estimates and Forecasts (2018-2029)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Newcastle Disease Vaccine Market Competitive Landscape
- 3.1 Global Newcastle Disease Vaccine Sales by Manufacturers (2018-2023)
- 3.2 Global Newcastle Disease Vaccine Revenue Market Share by Manufacturers (2018-2023)
- 3.3 Newcastle Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4 Global Newcastle Disease Vaccine Average Price by Manufacturers (2018-2023)
- 3.5 Manufacturers Newcastle Disease Vaccine Sales Sites, Area Served, Product Type
- 3.6 Newcastle Disease Vaccine Market Competitive Situation and Trends
- 3.6.1 Newcastle Disease Vaccine Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest Newcastle Disease Vaccine Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 Newcastle Disease Vaccine Industry Chain Analysis
- 4.1 Newcastle Disease Vaccine Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Newcastle Disease Vaccine Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 New Product Developments
- 5.5.2 Mergers & Acquisitions
- 5.5.3 Expansions
- 5.5.4 Collaboration/Supply Contracts
- 5.6 Industry Policies
- 6 Newcastle Disease Vaccine Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Newcastle Disease Vaccine Sales Market Share by Type (2018-2023)
- 6.3 Global Newcastle Disease Vaccine Market Size Market Share by Type (2018-2023)
- 6.4 Global Newcastle Disease Vaccine Price by Type (2018-2023)
- 7 Newcastle Disease Vaccine Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Newcastle Disease Vaccine Market Sales by Application (2018-2023)
- 7.3 Global Newcastle Disease Vaccine Market Size (M USD) by Application (2018-2023)
- 7.4 Global Newcastle Disease Vaccine Sales Growth Rate by Application (2018-2023)
- 8 Newcastle Disease Vaccine Market Segmentation by Region
- 8.1 Global Newcastle Disease Vaccine Sales by Region
- 8.1.1 Global Newcastle Disease Vaccine Sales by Region
- 8.1.2 Global Newcastle Disease Vaccine Sales Market Share by Region
- 8.2 North America
- 8.2.1 North America Newcastle Disease Vaccine Sales by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe Newcastle Disease Vaccine Sales by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Russia
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific Newcastle Disease Vaccine Sales by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America Newcastle Disease Vaccine Sales by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa Newcastle Disease Vaccine Sales by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 Merial
- 9.1.1 Merial Newcastle Disease Vaccine Basic Information
- 9.1.2 Merial Newcastle Disease Vaccine Product Overview
- 9.1.3 Merial Newcastle Disease Vaccine Product Market Performance
- 9.1.4 Merial Business Overview
- 9.1.5 Merial Newcastle Disease Vaccine SWOT Analysis
- 9.1.6 Merial Recent Developments
- 9.2 CEVA
- 9.2.1 CEVA Newcastle Disease Vaccine Basic Information
- 9.2.2 CEVA Newcastle Disease Vaccine Product Overview
- 9.2.3 CEVA Newcastle Disease Vaccine Product Market Performance
- 9.2.4 CEVA Business Overview
- 9.2.5 CEVA Newcastle Disease Vaccine SWOT Analysis
- 9.2.6 CEVA Recent Developments
- 9.3 QYH Biotech
- 9.3.1 QYH Biotech Newcastle Disease Vaccine Basic Information
- 9.3.2 QYH Biotech Newcastle Disease Vaccine Product Overview
- 9.3.3 QYH Biotech Newcastle Disease Vaccine Product Market Performance
- 9.3.4 QYH Biotech Business Overview
- 9.3.5 QYH Biotech Newcastle Disease Vaccine SWOT Analysis
- 9.3.6 QYH Biotech Recent Developments
- 9.4 Ringpu Biology
- 9.4.1 Ringpu Biology Newcastle Disease Vaccine Basic Information
- 9.4.2 Ringpu Biology Newcastle Disease Vaccine Product Overview
- 9.4.3 Ringpu Biology Newcastle Disease Vaccine Product Market Performance
- 9.4.4 Ringpu Biology Business Overview
- 9.4.5 Ringpu Biology Newcastle Disease Vaccine SWOT Analysis
- 9.4.6 Ringpu Biology Recent Developments
- 9.5 Yebio
- 9.5.1 Yebio Newcastle Disease Vaccine Basic Information
- 9.5.2 Yebio Newcastle Disease Vaccine Product Overview
- 9.5.3 Yebio Newcastle Disease Vaccine Product Market Performance
- 9.5.4 Yebio Business Overview
- 9.5.5 Yebio Newcastle Disease Vaccine SWOT Analysis
- 9.5.6 Yebio Recent Developments
- 9.6 Harbin Veterinary Research Institute
- 9.6.1 Harbin Veterinary Research Institute Newcastle Disease Vaccine Basic Information
- 9.6.2 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Overview
- 9.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Market Performance
- 9.6.4 Harbin Veterinary Research Institute Business Overview
- 9.6.5 Harbin Veterinary Research Institute Recent Developments
- 9.7 Merck Animal Health
- 9.7.1 Merck Animal Health Newcastle Disease Vaccine Basic Information
- 9.7.2 Merck Animal Health Newcastle Disease Vaccine Product Overview
- 9.7.3 Merck Animal Health Newcastle Disease Vaccine Product Market Performance
- 9.7.4 Merck Animal Health Business Overview
- 9.7.5 Merck Animal Health Recent Developments
- 9.8 DHN
- 9.8.1 DHN Newcastle Disease Vaccine Basic Information
- 9.8.2 DHN Newcastle Disease Vaccine Product Overview
- 9.8.3 DHN Newcastle Disease Vaccine Product Market Performance
- 9.8.4 DHN Business Overview
- 9.8.5 DHN Recent Developments
- 9.9 Zoetis
- 9.9.1 Zoetis Newcastle Disease Vaccine Basic Information
- 9.9.2 Zoetis Newcastle Disease Vaccine Product Overview
- 9.9.3 Zoetis Newcastle Disease Vaccine Product Market Performance
- 9.9.4 Zoetis Business Overview
- 9.9.5 Zoetis Recent Developments
- 9.10 ChengDu Tecbond
- 9.10.1 ChengDu Tecbond Newcastle Disease Vaccine Basic Information
- 9.10.2 ChengDu Tecbond Newcastle Disease Vaccine Product Overview
- 9.10.3 ChengDu Tecbond Newcastle Disease Vaccine Product Market Performance
- 9.10.4 ChengDu Tecbond Business Overview
- 9.10.5 ChengDu Tecbond Recent Developments
- 9.11 Elanco (Lohmann)
- 9.11.1 Elanco (Lohmann) Newcastle Disease Vaccine Basic Information
- 9.11.2 Elanco (Lohmann) Newcastle Disease Vaccine Product Overview
- 9.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Product Market Performance
- 9.11.4 Elanco (Lohmann) Business Overview
- 9.11.5 Elanco (Lohmann) Recent Developments
- 9.12 FATRO
- 9.12.1 FATRO Newcastle Disease Vaccine Basic Information
- 9.12.2 FATRO Newcastle Disease Vaccine Product Overview
- 9.12.3 FATRO Newcastle Disease Vaccine Product Market Performance
- 9.12.4 FATRO Business Overview
- 9.12.5 FATRO Recent Developments
- 9.13 CAVAC
- 9.13.1 CAVAC Newcastle Disease Vaccine Basic Information
- 9.13.2 CAVAC Newcastle Disease Vaccine Product Overview
- 9.13.3 CAVAC Newcastle Disease Vaccine Product Market Performance
- 9.13.4 CAVAC Business Overview
- 9.13.5 CAVAC Recent Developments
- 9.14 Vaksindo
- 9.14.1 Vaksindo Newcastle Disease Vaccine Basic Information
- 9.14.2 Vaksindo Newcastle Disease Vaccine Product Overview
- 9.14.3 Vaksindo Newcastle Disease Vaccine Product Market Performance
- 9.14.4 Vaksindo Business Overview
- 9.14.5 Vaksindo Recent Developments
- 10 Newcastle Disease Vaccine Market Forecast by Region
- 10.1 Global Newcastle Disease Vaccine Market Size Forecast
- 10.2 Global Newcastle Disease Vaccine Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe Newcastle Disease Vaccine Market Size Forecast by Country
- 10.2.3 Asia Pacific Newcastle Disease Vaccine Market Size Forecast by Region
- 10.2.4 South America Newcastle Disease Vaccine Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Consumption of Newcastle Disease Vaccine by Country
- 11 Forecast Market by Type and by Application (2024-2029)
- 11.1 Global Newcastle Disease Vaccine Market Forecast by Type (2024-2029)
- 11.1.1 Global Forecasted Sales of Newcastle Disease Vaccine by Type (2024-2029)
- 11.1.2 Global Newcastle Disease Vaccine Market Size Forecast by Type (2024-2029)
- 11.1.3 Global Forecasted Price of Newcastle Disease Vaccine by Type (2024-2029)
- 11.2 Global Newcastle Disease Vaccine Market Forecast by Application (2024-2029)
- 11.2.1 Global Newcastle Disease Vaccine Sales (K MT) Forecast by Application
- 11.2.2 Global Newcastle Disease Vaccine Market Size (M USD) Forecast by Application (2024-2029)
- 12 Conclusion and Key Findings
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook